Recently, more than 40,000 clinicians, researchers and other healthcare professionals
convened in Chicago for the 2019 American Society of Clinical Oncology (ASCO) annual
meeting to guage where we are in cancer research and where we still need to go.
The Leukemia & Lymphoma Society (LLS) is excited by the incredible progress we're seeing
in the fight against blood and other cancers.With our investment of nearly $1.3 billion
in research since our founding 70 years ago, we're leaders in advancing breakthroughs in
immunotherapy, genomics and precision medicine. And we've recently doubled our commitment
to bringing safer, more effective treatments to children with blood cancers.
Many of these pioneering areas were in the spotlight at ASCO, including changes in pediatric
cancer, and hold promising news for patients.
To ensure future delivery of emails,
please add newsletter@email.lis.org to your safe sendor list or address book.
This email was sent to:
1234@gmail.com
